BCR and prostate adenocarcinoma: Using the multivariable Cox regression analysis, we found this risk signature could be a well independent predictor of BCR for PRAD patients, independently of age, gender, and other confounding factors in TCGA (p < 0.001, Figure 4(b)) and GEO (p = 0.030, Figure 4(d)) cohorts.